Development and validation of a prediction model for 1-year mortality among older adults with Hodgkin Lymphoma who receive dose-intense chemotherapy
Authors:
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 12 (8) , 1233-1239
Abstract
No abstract availableKeywords
Funding Information
- National Center for Advancing Translational Sciences
- National Institutes of Health (TL1TR002546)
This publication has 28 references indexed in Scilit:
- Receiver Operating Characteristic Curve in Diagnostic Test AssessmentJournal of Thoracic Oncology, 2010
- Ongoing improvement in long-term survival of patients with Hodgkin disease at all ages and recent catch-up of older patientsBlood, 2008
- Epstein-Barr Virus As a Marker of Survival After Hodgkin's Lymphoma: A Population-Based StudyJournal of Clinical Oncology, 2005
- A metaanalysis of 18F‐2‐deoxy‐2‐fluoro‐D‐glucose positron emission tomography in the staging and restaging of patients with lymphomaCancer, 2005
- Independent prognostic effect of co-morbidity in lymphoma patients: Results of the population-based Eindhoven Cancer RegistryEuropean Journal of Cancer, 2005
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998
- Outcome of Hodgkin's disease in elderly patientsHematological Oncology, 1995
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- Hodgkin's disease and age*European Journal of Haematology, 1989